Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA's Rx Promotion Citation Drought Continued In 2015

This article was originally published in The Pink Sheet Daily

Executive Summary

First Amendment litigation and guidance document work may be factors behind decline.

You may also be interested in...



FDA’s Rx Promo Citations Rise Slightly In 2016; Investigational Drug Promos Scrutinized

Office of Prescription Drug Promotion seemed to expand its focus in issuing 11 letters last year.

FDA’s Promotional Enforcement Still Playing It Safe

Even with letter citing Spanish video for Oxtellar seizure, US regulatory agency likely to issue record low number of letters this year.

FDA's Drug Promotion Advisory Reviews Taking Longer

FDA is having trouble meeting its internal goal of 45-day reviews for core launch materials due to complex issues that have required medical review division consultations, Office of Prescription Drug Promotion Director Abrams says.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS079067

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel